News | April 01, 2008

MITA Confirms CTA is Cost-Saving for Suspected CAD

April 2, 2008 - The Medical Imaging and Technology Alliance (MITA) said that the recent multi-center study presented Tuesday by Cardiologist James K. Min, M.D., at the 57th Annual Meeting of the American College of Cardiology in Chicago demonstrates that coronary computed tomographic angiography (CCTA) is cost-saving for patients with suspected coronary artery disease (CAD). CCTA is a medical imaging tool that detects CAD without surgery or catheterization within seconds. Dr. Min's study found the cost savings of the two leading non-invasive methods for detecting CAD varies based on the patient's heart history. Patients who underwent CCTA without prior diagnosis of CAD cost $603 less per patient compared to those who underwent myocardial perfusion imaging (MPI or SPECT). Both groups had equal clinical outcomes. "This study's findings further substantiate medical imaging technology as a cost-effective diagnostic tool for patients with suspected coronary artery disease," said Andrew Whitman, vice president, MITA. "MITA applauds the work of Dr. Min and his team at New York Presbyterian/Weill Cornell. Their findings remind us that patients deserve access to innovative medical imaging technology to help fight heart disease." CCTA has widespread acceptance as a proven technology to rule out heart disease with greater than 99 percent accuracy, according to a statement by MITA. This technology is used in more than 2,000 centers nationwide and has been approved by local Medicare carriers in all 50 states. "CCTA has become a standard of care for diagnosing and treating cardiac disease throughout the country and the world," said Whitman. "Studies like these remind us why it is crucial that policymakers turn to results-based findings and permit continued access to this state-of-the-art diagnostic tool for heart disease patients nationwide. Medical imaging works for patients by facilitating better diagnoses and works for healthcare providers by reducing costs." For more information: www.medicalimaging.org

Related Content

HeartFlow Analysis Successfully Stratifies Heart Disease Patients at One Year
News | CT Angiography (CTA) | March 19, 2019
Late-breaking results confirm the HeartFlow FFRct (fractional flow reserve computed tomography) Analysis enables...
Aidoc Announces CE Mark for AI-based Pulmonary Embolism Workflow Tool
News | Computed Tomography (CT) | March 04, 2019
Artificial intelligence (AI) radiology solution provider Aidoc announced the commercial release of its CE-marked...
Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
CT Offers Non-Invasive Alternative for Complex Coronary Disease Treatment Planning
News | CT Angiography (CTA) | October 16, 2018
A new study published in the European Heart Journal shows computed tomography (CT) can be a useful aid in heart team...

Image courtesy of Siemens Healthineers

Feature | CT Angiography (CTA) | September 06, 2018 | Dave Fornell
There have been a few big, recent advancements in cardiac computed tomography angiography (CCTA) imaging technology....
iSchemaView RAPID Technology Now Installed in More Than 500 Stroke Centers
News | Neuro Imaging | August 27, 2018
iSchemaView announced that more than 575 stroke centers in 22 countries have selected the RAPID advanced imaging...
Videos | Computed Tomography (CT) | July 25, 2018
A discussion with Patricia Dickson, LRT(CT), director of imaging and outpatient services, Capital Cardiology Associat
iSchemaView Brings RAPID Imaging Platform to Australia and New Zealand
News | Stroke | July 13, 2018
iSchemaView has signed Diagnostic Imaging Australia (DIA) to be the exclusive distributor for the RAPID cerebrovascular...